PeptideQC Global

Batch 20260609 · Reported 25 June 2026

Batch evidence: retatrutide lot 20260609

Not for human or animal use. This page publishes analytical data for a research-use-only material supplied to qualified laboratories. It is not a medical, therapeutic, safety or efficacy statement of any kind.

The certificate

Below is the complete certificate of analysis for batch 20260609, exactly as issued by the laboratory, with three redactions that are explained further down.

Certificate of analysis for retatrutide batch 20260609 from ACS Laboratory: 99.9% purity by LCMS-UV, accession AAHT398, with the client name, QR code and vial label redacted
Open the certificate as PDFThe issuing laboratory

Who tested it

Batch 20260609 was analysed by ACS Laboratory (ACS Peptide Testing Labs), 721 Cortaro Drive, Sun City Center, FL 33573, United States. The laboratory is accredited to ISO/IEC 17025:2017 under A2LA certificate 6786.01 and is DEA registered under number RA0447222. It is independent of PeptideQC Global and of Metatron Marketing Ltd., and the analysis was signed by Aixia Sun, Lab Director and Principal Scientist.

Reported results

ProductRetatrutide
Batch code20260609
Accession numberAAHT398
Purity99.9%, determined by LCMS-UV
Mass identificationRetatrutide, 99.9%
AppearanceWhite powder
Sample received15 June 2026
Reported25 June 2026